期刊文献+
共找到160篇文章
< 1 2 8 >
每页显示 20 50 100
Soluble interleukin-6 receptor is elevated during influenza A virus infection and mediates the IL-6 and IL-32 inflammatory cytokine burst 被引量:7
1
作者 Jun Wang Qing Wang Tao Han Yong-Kui Li Sheng-Li Zhu Fang Ao Jian Feng Ming-Zhen Jing Li Wang Lin-Bai Ye Ying Zhu 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2015年第5期633-644,共12页
Influenza A virus (IAV) infection is a major worldwide public health problem. However, the factors involved in mediating the inflammatory response to this infection and their relationships remain poorly understood. ... Influenza A virus (IAV) infection is a major worldwide public health problem. However, the factors involved in mediating the inflammatory response to this infection and their relationships remain poorly understood. Here, we show that IAV infection stimulates the expression of the soluble IL-6 receptor (slL-6R), a multifunctional protein involved in IL-6 signaling. Interestingly, slL-6R expression upregulated the levels of its own ligand, IL-6 and those of the pro-inflammatory cytokine IL-32. shRNA-mediated knockdown of slL-6R suppressed I L-6 and IL-32, indicating that this regulation is dependent on slL-6R during IAV infection. Furthermore, our results demonstrate that IL-32 participates in a negative feedback loop that inhibits slL-6R while upregulating IL-6 expression during IAV infection. Therefore, we show that slL-6R is a critical cellular factor involved in the acute inflammatory response to viral infection. 展开更多
关键词 IL-32 IL-6 inflammation network influenza A virus soluble IL-6 receptor
原文传递
Changes in soluble interleukin-2 receptor level in serum and Na^+ -K^+ -exchanging ATPase activity in semen of infertile men caused by antisperm antibody 被引量:8
2
作者 Jiang NI Qing-Lei LI +2 位作者 Wei ZHANG Jian-Song XIE Shu-Ling BIAN Department of Physiology, Harbin Medical University, Harbin 150086, China 《Asian Journal of Andrology》 SCIE CAS CSCD 2000年第2期151-153,共3页
Aim: To explore the possible mechanisms of male infertility caused by antisperm antibody (AsAb). Methods: Thesoluble interleukin-2 receptor (sIL-2R) level in serum was analyzed by ELISA and Na^+ -K^+ -exchanging ATPas... Aim: To explore the possible mechanisms of male infertility caused by antisperm antibody (AsAb). Methods: Thesoluble interleukin-2 receptor (sIL-2R) level in serum was analyzed by ELISA and Na^+ -K^+ -exchanging ATPase activi-ty in semen by phosphorus (Pi) assay. Results: The slL-2R level in serum was significantly higher and the Na^+ -K^+ -exchanging ATPase activity in semen significantly lower in AsAb positive infertile men when compared with thecontrols. Conclusion: The AsAb titer varies with the slL-2R level in serum. A decrease in Na^+ -K^+ -exchangingATPase activity in semen may play a role in male infertility caused by AsAb. 展开更多
关键词 male infertility antisperm antibodies soluble interleukin-2 receptor Na^+-K^+-exchanging ATPase
下载PDF
Study of the Effect of Leeching on Plasma Endothelin and Soluble Interleukin-2 Receptor in Patients with Systemic Lupus Erythematosus 被引量:2
3
作者 程世平 刘加林 袁静 《Chinese Journal of Integrated Traditional and Western Medicine》 2005年第1期65-68,共4页
Objective: to explore the mechanism of leeching in treating systemic lupus erythematosus (SLE). Methods: Forty-four patients with SLE were randomly divided into conventional corticosteroid treated group (control group... Objective: to explore the mechanism of leeching in treating systemic lupus erythematosus (SLE). Methods: Forty-four patients with SLE were randomly divided into conventional corticosteroid treated group (control group, n =20) and conventional treatment group with leeching intervention added (leeching group, n =24). Before and after treatment the concentration of plasma endothelin (ET) and soluble interleukin-2 receptor (sIL-2R) were determined. Results: Before treatment the level of plasma ET and sIL-2R in the SLE patients were all higher than those in the normal healthy group, ( P <0.01). But after treatment the level of these in both groups were significantly improved than those of before treatment ( P <0.05), and comparison between these two treated groups showed that the difference between them was significant ( P <0.05). Conclusion: Leeching added to conventional treatment of SLE could be more effective in improving the level of plasma ET and sIL-2R, and ameliorating the impairment of renal tissues. 展开更多
关键词 systemic lupus erythematosus ENDOTHELIN soluble interleukin-2 receptor LEECH
下载PDF
Elevated pancreatic enzymes, IgM, soluble interleukin-2 receptor in anti-GADab(+) type 1 diabetes 被引量:1
4
作者 Hidekatsu Yanai Sumie Moriyama 《World Journal of Diabetes》 SCIE CAS 2011年第5期75-76,共2页
Type 1 diabetes can be classified into immune-mediated diabetes (type 1A) and idiopathic diabetes, which lacks immunological evidence for beta cell autoimmunity (type 1B). Type 1A diabetes is characterized by the pres... Type 1 diabetes can be classified into immune-mediated diabetes (type 1A) and idiopathic diabetes, which lacks immunological evidence for beta cell autoimmunity (type 1B). Type 1A diabetes is characterized by the presence of the anti-glutamic acid decarboxylase antibody (anti-GADab). Fulminant type 1 diabetes is classified as type 1B diabetes, and characterized by the absence of anti-GADab, flu-like symptoms, and elevated serum exocrine pancreatic enzymes. We report a type 1 diabetic patient who showed flu-like symptoms, elevated serum exocrine pancreatic enzymes, and an extremely high-titer of anti-GADab, manifesting the characteristics of both type 1A and fulminant type 1 diabetes. 展开更多
关键词 Anti-glutamic acid DECARBOXYLASE antibody EXOCRINE pancreatic ENZYMES Type 1 diabetes soluble interleukin-2 receptor
下载PDF
Effects of Aprotinin on Serum Interleukin-2 and Soluble Interleukin-2 Receptor during Cardiopulmonary Bypass 被引量:1
5
作者 罗军 汪东仿 +1 位作者 蓝鸿钧 孙宗全 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2000年第2期143-144,共2页
Interleukin-2 and its receptor are of importance in regulating immunity responses. The changes of interleukin-2 (IL-2) and soluble interleukin-2 receptor (IL-2R) during heart valve (s) replacement operation and effec... Interleukin-2 and its receptor are of importance in regulating immunity responses. The changes of interleukin-2 (IL-2) and soluble interleukin-2 receptor (IL-2R) during heart valve (s) replacement operation and effects of aprotinin on them were observed. Twenty patients undergoing heart valve (s) replacement were randomly divided into two groups: control group (n=10) and apro- tinin group (n=10). In aprotinin group, 1 000 000 KIU aprotinin was given by vein injection and then 2 000 000 KIU was given as a bolus in prime. Blood samples were collected before CPB, right after CPB and on the 1st, 3rd and 7th postoperative day (POD) for serum IL-2 and sIL-2R determination. Results showed that after CPB, IL-2 was reduced and slL-2R increased. Meanwhile, serum IL-2R was lower in aprotinin group than that of control. It is concluded that the immunity depression after CPB is associated with low level of IL-2 and high level of sIL-2R and aprotinin can ameliorate the situation. 展开更多
关键词 cardiopulmonary bypass interleukin-2 soluble interleukin-2 receptor APROTININ
下载PDF
Glycosylation-independent binding to extracellular domains 11-13 of mannose-6-phosphate/insulin-like growth factor-2 receptor mediates the effects of soluble CREG on the phenotypic proliferation of vascular smooth muscle cells 被引量:5
6
作者 LUAN Bo~1,HAN Ya-ling~1,SUN Ming-yu~1,GUO Liang~1,GUO Peng~1,TAO Jie~1,DENG Jie~1,WU Guang-zhe~1,YAN Cheng-hui~1, LI Shao-hua~2 (1.Department of Cardiology,Shenyang Northern Hospital, Shenyang,China 2.Division of Vascular Surgery,Robert Wood Johnson Medical School-UMDNJ,New Jersey,USA) 《岭南心血管病杂志》 2011年第S1期186-186,共1页
Background The present study aimed to investigate the detailed mode and specific sites for their binding as well as the functional relevance of this binding in the phenotypic proliferation of vascular smooth muscle ce... Background The present study aimed to investigate the detailed mode and specific sites for their binding as well as the functional relevance of this binding in the phenotypic proliferation of vascular smooth muscle cells(SMCs). Methods CREG knocked-down SMCs were employed to evaluate the biological activity of wtCREG and mCREG.Expressions of SMC differentiation markers SM myosin heavy chain(SM-MHC),SM-actin,heavy caldesmon and myocardin were determined by Western blotting using specific antibodies. Cellular growth of SMCs was assessed by bromide dewuridine (BrdU) incorporation and cell cycle analysis on fluorescence-activated cell sorting(FACS).A solid-phase binding assay was used to study the binding of CREG to extracellular domains of M6P/IGF2R.The cellular co-localization of the two recombinant CREGs with M6P/IGF2R was detected on SMC surface by immunoprecipitation and immunofluorescence analysis.Results The molecular weight of wtCREG was around 30 kD while that of the mCREG was~25 kD.Treatment of wtCREG with PNGase F reduced its molecular weight from~30 kD to~25 kD,whereas PNGase F treatment had no effect on the molecular weight of mCREG.Both wtCREG and mCREG proteins enhanced SMC differentiation,inhibited BrdU incorporation,and arrested cell cycle progression when added to the culture medium.In CREG knocked-down SMCs,the amount of CREG detected by immunoblotting in M6P/IGF2R immunoprecipitates was significantly reduced when compared to normal cells.Both recombinant CREGs co-immunoprecipitated with M6P/IGF2R, although slightly reduced amount of the mutant CREG was detected in M6P/IGF2R immunoprecipitates.Immunostaining revealed that His-tagged CREGs co-localized with IGF2R on the cell surface in a glycosylation-independent manner.In vitro binding assay showed that CREGs bound to M6P/ IGF2R extracellular domains 7-10 and 11-13 in a glycosylation -dependent and -independent manner,respectively.Further blocking experiments using soluble M6P/IGF2R fragments and M6P/IGF2R neutralizing antibody indicated that the biological activities of recombinant CREGs in SMC growth and the up-regulation of SMC differentiation markers were all abolished by treatment with the M6P/IGF2R neutralizing antibody. However,although the growth inhibitory effect of wtCREG was nearly abolished by D7-10 or D11-13,the effect of mCREG was only reversed by Dll-13,indicating that the binding to domains 11-13 is required for CREG to modulate the proliferation of SMCs.Conclusions These data suggest that solubleCREG proteins can exert their biological function via binding to the extracellular domains 7-10 and 11-13 of cell surface M6P/IGF2R in both a glycosylation-dependent and -independent manner. 展开更多
关键词 CREG Glycosylation-independent binding to extracellular domains 11-13 of mannose-6-phosphate/insulin-like growth factor-2 receptor mediates the effects of soluble CREG on the phenotypic proliferation of vascular smooth muscle cells IGF
下载PDF
Plasma Levels of Growth Arrest Specific Protein (Gas6) and the Soluble Form of Its Tyrosine Kinase Receptor Axl (sAxl) in Patients with Hepatocellular Carcinoma 被引量:1
7
作者 Soichiro Uehara Katsuhiro Gotoh +1 位作者 Hiroshi Handa Yoshiyuki Maki 《Journal of Cancer Therapy》 2013年第2期632-639,共8页
The aim of this study was to determine the plasma levels of vitamin K-dependent protein growth arrest-specific protein 6 (Gas6) and its soluble receptor Axl (sAxl) in patients with hepatocellular carcinoma (HCC), acut... The aim of this study was to determine the plasma levels of vitamin K-dependent protein growth arrest-specific protein 6 (Gas6) and its soluble receptor Axl (sAxl) in patients with hepatocellular carcinoma (HCC), acute hepatitis (AH), fulminant hepatitis(FH), chronic hepatitis (CH), and liver cirrhosis (LC) and to determine whether Gas6 and sAxl can be used as biomarkers. Immunoassys were used to measure levels of plasma Gas6 and sAxl in 40 patients with HCC, 13 patients with AH, 3 patients with FH, 7 patients with LC, and 20 healthy normal adult controls (NC). Furthermore, urinary γ-carboxyglutamic acid (Gla) was measured by high performance liquid chromatography. We have addressed this issue by conducting a cross-sectional study to determine whether plasma Gas6 and sAxl levels are associated with DCP, urinary γ-Gla, and liver functions in humans. Levels of Gas6, sAxl, and γ-Gla were significantly higher in HCC as compared to those in NC, and they were significantly positive correlated. Gas6/sAxl molar ratios in HCC were significantly higher than in NC, but those ratios in AH, FH, and LC were significantly lower in NC. Furthermore, Gas6/sAxl molar ratios in HCC increased significantly in comparison with those AH and LC. The increase of Gas6, sAxl and Gas6/sAxl molar ratio were correlated with the progression and poor prognosis of HCC. Thus, Gas6 and sAxl may be useful biomarkers for HCC. 展开更多
关键词 GAS6 soluble AXL (sAxl) receptor TYROSINE Kinase γ-Carboxyglutamic Acid (γ-Gla) VITAMIN K Hepatocellular Carcinoma (HCC)
下载PDF
The interleukin-1 receptor antagonist (IL-1-Ra) and soluble tumor necrosis factor receptor I (sTNF RI) in periodontal disease
8
作者 Sylwia M. Slotwinska 《Open Journal of Immunology》 2013年第1期10-16,共7页
The course and severity of periodontitis can be significantly affected by bacterial virulence as well as host immunity dysfunction. Periodontal tissue destruction has been proved to result from cascade of cytokines sy... The course and severity of periodontitis can be significantly affected by bacterial virulence as well as host immunity dysfunction. Periodontal tissue destruction has been proved to result from cascade of cytokines synthesized by reactive cells upon stimulation by pathogenic bacteria and lipopolysaccharides within their cell membranes. The clinical use of genetically programmed cells, producing substances blocking IL-1, based on recombinant IL-1 antagonist, as well as cytokines activating fibroblasts and osteoblasts to regenerate the destroyed periodontal tissue could prove alternative to the conventional treatment. Another cytokine of interest in respect to periodontitis ethiopathogenesis is soluble tumor necrosis factor receptor I (sTNF RI). Observation of soluble TNF receptors as physiologic inhibitors of TNF led to its administration in therapeutic process as well as in therapy selected cases of aggressive periodontitis. 展开更多
关键词 Periodontitis interleukin-1 receptor Antagonist (IL-1 Ra) soluble Tumor Necrosis Factor receptor I (sTNF RI)
下载PDF
血清TRAF6、activin-A、SFMC水平与子痫前期患者病情及妊娠结局的相关性
9
作者 高萃 崔金全 邵文嘉 《河南医学研究》 CAS 2024年第9期1583-1586,共4页
目的分析血清肿瘤坏死因子受体相关因子6(TRAF6)、糖蛋白激素-激活素A(activin-A)、可溶性纤维蛋白复合物(SFMC)水平与子痫前期患者病情及妊娠结局的相关性。方法回顾性选取2020年7月至2023年1月郑州大学第二附属医院收治的134例子痫前... 目的分析血清肿瘤坏死因子受体相关因子6(TRAF6)、糖蛋白激素-激活素A(activin-A)、可溶性纤维蛋白复合物(SFMC)水平与子痫前期患者病情及妊娠结局的相关性。方法回顾性选取2020年7月至2023年1月郑州大学第二附属医院收治的134例子痫前期患者为研究组,另选取同期健康孕检女性为对照组,根据子痫前期患者病情程度分为轻度、重度患者,所有患者均随访至分娩结束后30 d,根据本次妊娠结局是否发生不良妊娠情况将研究组分为发生、未发生患者。对比对照组和研究组、不同病情程度及不同妊娠结局患者入院时血清TRAF6、activin-A、SFMC水平,并分析其相关性,分析入院时血清各指标水平检测对子痫前期患者妊娠结局的预测价值。结果研究组入院时血清TRAF6、activin-A、SFMC水平高于对照组(P<0.05);重度患者血清TRAF6、activin-A、SFMC水平高于轻度患者(P<0.05);入院时血清TRAF6、activin-A、SFMC均与患者病情程度呈正相关(P<0.05);妊娠不良患者入院时血清TRAF6、activin-A、SFMC水平高于妊娠良好患者(P<0.05);入院时血清TRAF6、activin-A、SFMC水平联合预测子痫前期患者妊娠不良的曲线下面积(AUC)为0.748。结论血清TRAF6、activin-A、SFMC表达与子痫前期患者病情程度及预后密切相关,其三者联合检测对预测子痫前期患者妊娠不良具有较高的应用价值,可辅助临床诊疗。 展开更多
关键词 子痫前期 肿瘤坏死因子受体相关因子6 糖蛋白激素-激活素A 可溶性纤维蛋白复合物 妊娠结局
下载PDF
Tenascin C upregulates interleukin-6 expression in human cardiac myofibroblasts via toll-like receptor 4 被引量:4
10
作者 Azhar Maqbool Emma J Spary +7 位作者 Iain W Manfield Michaela Ruhmann Lorena Zuliani-Alvarez Filomena O Gamboa-Esteves Karen E Porter Mark J Drinkhill Kim S Midwood Neil A Turner 《World Journal of Cardiology》 CAS 2016年第5期340-350,共11页
AIM:To investigate the effect of Tenascin C(TNC)on the expression of pro-inflammatory cytokines and matrixmetalloproteinases in human cardiac myofibroblasts(CMF).METHODS:CMF were isolated and cultured from patients un... AIM:To investigate the effect of Tenascin C(TNC)on the expression of pro-inflammatory cytokines and matrixmetalloproteinases in human cardiac myofibroblasts(CMF).METHODS:CMF were isolated and cultured from patients undergoing coronary artery bypass grafting.Cultured cells were treated with either TNC(0.1μmol/L,24 h)or a recombinant protein corresponding to different domains of the TNC protein;fibrinogen-like globe(FBG)and fibronectin typeⅢ-like repeats(TNⅢ5-7)(both 1μmol/L,24 h).The expression of the proinflammatory cytokines;interleukin(IL)-6,IL-1β,TNFαand the matrix metalloproteinases;MMPs(MMP1,2,3,9,10,MT1-MMP)was assessed using real time RT-PCR and western blot analysis.RESULTS:TNC increased both IL-6 and MMP3(P<0.01)mR NA levels in cultured human CMF but had no significant effect on the other markers studied.The increase in IL-6 mR NA expression was mirrored by an increase in protein secretion as assessed by enzymelinked immunosorbant assay(P<0.01).Treating CMF with the recombinant protein FBG increased IL-6mR NA and protein(P<0.01)whereas the recombinant protein TNⅢ5-7 had no effect.Neither FBG nor TNⅢ5-7 had any significant effect on MMP3 expression.The expression of toll-like receptor 4(TLR4)in human CMF was confirmed by real time RT-PCR,western blot and immunohistochemistry.Pre-incubation of cells with TLR4neutralising antisera attenuated the effect of both TNC and FBG on IL-6 mR NA and protein expression.CONCLUSION:TNC up-regulates IL-6 expression in human CMF,an effect mediated through the FBG domain of TNC and via the TLR4 receptor. 展开更多
关键词 TENASCIN C Matrix METALLOPROTEINASE Tolllike receptor interleukin-6 Cardiac FIBROBLASTS
下载PDF
高尿酸痛风患者血清sICAM-1、IL-6、sCD163水平的变化及临床意义
11
作者 余玲 王秀成 +2 位作者 徐娜 张立赟 付文涛 《海南医学》 CAS 2024年第8期1140-1144,共5页
目的检测高尿酸痛风患者血清可溶性细胞间黏附分子-1(sICAM-1)、白细胞介素-6(IL-6)、可溶性单核巨噬细胞血红蛋白清道夫受体(sCD163)水平并探讨其临床意义。方法选取2020年1月至2023年1月南阳豫西健和医院收治的200例高尿酸血症(HUA)... 目的检测高尿酸痛风患者血清可溶性细胞间黏附分子-1(sICAM-1)、白细胞介素-6(IL-6)、可溶性单核巨噬细胞血红蛋白清道夫受体(sCD163)水平并探讨其临床意义。方法选取2020年1月至2023年1月南阳豫西健和医院收治的200例高尿酸血症(HUA)患者纳入研究,其中92例痛风患者作为观察组,108例无症状患者作为对照组,所有患者均检测血清sICAM-1、IL-6、sCD163水平及血尿酸含量。比较两组患者的血清sICAM-1、IL-6、sCD163水平及血尿酸含量。采用Pearson相关性、多元线性回归分析血清sICAM-1、IL-6、sCD163水平与血尿酸含量的相关性。采用相对危险度(RR)分析血清sICAM-1、IL-6、sCD16对高尿酸痛风发病风险的影响,绘制受试者工作特征曲线(ROC)评价血清sICAM-1、IL-6、sCD163对高尿酸痛风的诊断价值。结果观察组患者的血清sICAM-1、IL-6、sCD163水平和血尿酸含量分别为(574.26±95.22)ng/mL、(50.12±8.27)ng/L、(825.83±198.22)pg/mL、(582.37±156.92)μmol/L,明显高于对照组的(401.47±42.83)ng/mL、(39.82±6.13)ng/L、(694.28±114.83)pg/mL、(425.77±114.83)μmol/L,差异均有统计学意义(P<0.05);经Pearson相关性分析结果显示,高尿酸痛风患者血清sICAM-1、IL-6、sCD163水平与血尿酸水平呈显著正相关(P<0.05);经线性回归建立回归模型分析结果显示,高尿酸痛风患者血清sICAM-1、IL-6、sCD163水平与血尿酸水平呈极显著相关(P<0.01);HUA患者血清sICAM-1≥483.41 ng/mL、IL-6≥44.70 ng/L、sCD16≥598.93 pg/mL时,高尿酸痛风发病风险分别是血清sICAM-1<483.41 ng/mL、IL-6<44.70 ng/L、sCD16<598.93 pg/mL的5.133倍(95%CI:3.181~8.285)、4.412倍(95%CI:2.820~6.903)、3.600倍(95%CI:2.388~5.428);经ROC分析结果显示,血清sICAM-1、IL-6、sCD163诊断高尿酸痛风的曲线下面积(AUC)分别为0.775、0.731、0.792,进一步分析结果显示,血清sICAM-1、IL-6、sCD163联合诊断AUC为0.940,明显较各时间点单个指标大(P<0.05)。结论高尿酸痛风患者血清sICAM-1、IL-6、sCD163明显升高,且与血尿酸密切相关,临床检测其水平有助于疾病诊断。 展开更多
关键词 高尿酸血症 痛风 可溶性细胞间黏附分子-1 白细胞介素-6 可溶性单核巨噬细胞血红蛋白清道夫受体 相关性
下载PDF
大鼠压力性损伤皮肤皮下组织中IL-6受体表达及其意义
12
作者 董正惠 李振刚 +3 位作者 祁进芳 王志伟 田旭功 马小飞 《新疆医科大学学报》 CAS 2024年第1期33-38,共6页
目的观察大鼠压力性损伤组织中膜结合型IL-6受体(mIL-6R)和可溶型IL-6受体(sIL-6R)及受其调控的细胞因子表达水平,探讨IL-6受体对压力性损伤发生发展的影响及机制。方法将60只雄性SD大鼠随机分为正常对照组(n=20)、压力性损伤模型组(n=... 目的观察大鼠压力性损伤组织中膜结合型IL-6受体(mIL-6R)和可溶型IL-6受体(sIL-6R)及受其调控的细胞因子表达水平,探讨IL-6受体对压力性损伤发生发展的影响及机制。方法将60只雄性SD大鼠随机分为正常对照组(n=20)、压力性损伤模型组(n=20)、sgp130Fc(特异性IL-6反式信号通路阻断剂)预处理组(n=20)。正常对照组不做任何处理;压力性损伤模型组在麻醉下于股薄肌处建立压力性损伤模型;sgp130Fc预处理组大鼠在麻醉前30 min给予sgp130Fc 250 ng腹腔内注射,随后在麻醉下采取与压力性损伤模型组相同的方法建立压力性损伤模型。大鼠建立压力性损伤模型成功后分别取股薄肌处组织及血液,运用ELISA法检测血液中IL-6、sIL-6R表达水平,运用免疫组化法检测组织中mIL-6R、细胞间黏附分子-1(ICAM-1)、血管内皮生长因子(VEGF)及凋亡因子(Bcl-2、Bax、Caspase-3)的表达。运用Tunel法观察组织中细胞凋亡水平。结果与正常对照组大鼠相比,压力性损伤模型组大鼠血液中IL-6、sIL-6R及组织中ICAM-1、Bax、Caspase-3表达明显增加(P<0.05),而组织中mIL-6R、VEGF表达减少(P<0.05)。sgp130Fc预处理组大鼠组织中mIL-6R、VEGF、Bcl-2的表达与压力性损伤模型组大鼠相比无明显差异(P>0.05),ICAM-1、Bax、Caspase-3的表达及细胞凋亡指数明显低于压力性损伤模型组大鼠(P<0.05)。结论压力性损伤大鼠组织中mIL-6R表达减少,血液中sIL-6R水平异常升高。异常升高的sIL-6R可上调炎症因子和凋亡因子表达,促使压力性损伤发生。 展开更多
关键词 动物模型 压力性损伤 白介素6 白介素6受体 可溶性IL-6受体
下载PDF
Soluble Interleukin 2 Receptor-Alpha (sIL-2Rα) in the Peripheral Blood of Dogs—Comparison of Malignant Neoplasia with Other Diseases
13
作者 Christian Prachar Franz-Josef Kaup Stephan Neumann 《Open Journal of Veterinary Medicine》 2013年第2期176-183,共8页
Background: Cytokines are mediators of diseases. Expression levels in the blood could be of clinical relevance. Objective: sIL-2Rα is used as a marker for different malignancies in human medicine. The aim of this stu... Background: Cytokines are mediators of diseases. Expression levels in the blood could be of clinical relevance. Objective: sIL-2Rα is used as a marker for different malignancies in human medicine. The aim of this study was to show if sIL-2Rα is detectable and if there is any correlation to different diseases in dogs. Methods: For this purposes sIL-2Rα concentrations in the blood were measured in healthy dogs, in dogs with different non-neoplastic diseases and benign tumors and in dogs with malignant tumors. Serum levels of sIL-2Rα were measured by using a human specific enzyme linked immunosorbent assay (ELISA). Results: Measurement of sIL-2Rα was successful in most of the samples. Dogs with diseases have significantly increased serum levels of sIL-2Rα compared to healthy controls. sIL-2Rα serum levels are higher in patients with non-neoplastic diseases and benign tumors than in those with malignant neoplasia. There is a strong correlation between sIL-2Rα and leukocyte count. Conclusion: Measurements of sIL-2Rα in serum may be helpful in detecting stages and grades of inflammation in the progression of disease. sIL-2Rα could actually not be used as an indicator for malignant diseases in dogs like in humans. The strong correlation between sIL-2Rα and the leukocyte count indicates the inflammatory response to the disease. This could be helpful in giving a prognosis in some cases, because the inflammatory reaction is of prognostic relevance in different diseases including malignant and non-malignant neoplasia. Although the results of our research studies were very promising, further studies should be performed with a canine ELISA. 展开更多
关键词 SIL-2RΑ soluble interleukin-2 receptor Alpha ELISA Dog
下载PDF
DETECTION OF PLASMA SOLUBLE INTERLEUKIN-2 RECEPTOR IN PATIENTS WITH SEVERE AND CHRONIC ACTIVE HEPATITIS B
14
作者 张树林 吴广利 +3 位作者 严玉兰 陈太平 赵英仁 李义方 《Journal of Pharmaceutical Analysis》 CAS 1994年第1期11-14,25,共5页
Plasma levels of soluble interleukin-2 receptor (sIL-2R) in patients with chronic active hepatitis B (CAHB) or severe hepatitis B (SHB) were measured quantitatively by 'sandwich' ELISA with monoclonal antibodi... Plasma levels of soluble interleukin-2 receptor (sIL-2R) in patients with chronic active hepatitis B (CAHB) or severe hepatitis B (SHB) were measured quantitatively by 'sandwich' ELISA with monoclonal antibodies in order to explore the change of sIL-2R levels, its clinical significance,and its relation to liver damage. The results showed that the plasma sIL-2R levels in patients with CAHB and SHB were much higher than those in normal controls (P < 0. 01 ), and the level ofplasma sIL-2R in patients with SHB was greatly higher than that in patients with CAHB. These results suggest that there is close relation between plasma level of sIL-2R, the clinical types of hepatitis B,and the severity of liver damage. In addition, there is no significant difference in plasma levels of sIL-2R between acute severe hepatitis B (ASHB), subacute severe hepatitis B (SASHB), and chronic severe hepatitis B (CSHB). No relation was found between sIL-2R level and hepatitis B virusreplication activity. 展开更多
关键词 chronic active hepatitis B (CAHB) severe hepatitis B (SHB) soluble interleukin-2 receptor (sIL-2R)
下载PDF
ET-1、IL-6以及可溶性白介素-2受体与颅脑损伤后脑血管痉挛的相关性分析
15
作者 皮亮 周雷廷 李子博 《医学理论与实践》 2024年第5期734-737,747,共5页
目的:探讨内皮素-1(ET-1)、白细胞介素-6(IL-6)以及可溶性白介素-2受体(SIL-2R)与颅脑损伤后脑血管痉挛的相关性。方法:选取我院2019年10月—2022年10月收治的102例颅脑损伤患者作为研究对象,均对所有患者采用经颅多普勒血流分析仪检测... 目的:探讨内皮素-1(ET-1)、白细胞介素-6(IL-6)以及可溶性白介素-2受体(SIL-2R)与颅脑损伤后脑血管痉挛的相关性。方法:选取我院2019年10月—2022年10月收治的102例颅脑损伤患者作为研究对象,均对所有患者采用经颅多普勒血流分析仪检测其平均血流速度,根据血流速度划分为单纯颅脑损伤组(36例)、轻症痉挛组(41例)、重症痉挛组(25例)。对比三组患者ET-1、IL-6、SIL-2R表达水平,并分析ET-1、IL-6、SIL-2R与颅脑损伤后脑血管痉挛的相关性。随后建立受试者特征工作(ROC)曲线,分析ET-1、IL-6、SIL-2R对颅脑损伤后脑血管痉挛的诊断效能。对66例颅脑损伤后脑血管痉挛患者进行随访,将治疗后重新进入ICU与院内死亡的21例患者分为预后不良组,将其余45例患者分为预后良好组,对比预后不良组和预后良好组患者临床一般情况,并分析ET-1、IL-6、SIL-2R对颅脑损伤后脑血管痉挛的预后预测价值。结果:重症痉挛组血清ET-1、IL-6、SIL-2R水平高于轻症痉挛组和单纯颅脑损伤组(P<0.05);Spearman相关分析结果显示,ET-1、IL-6、SIL-2R与颅脑损伤后脑血管痉挛呈正相关(P<0.05);ET-1、IL-6、SIL-2R及三者联合对颅脑损伤后脑血管痉挛的ROC曲线面积(AUC)依次为0.688、0.667、0.656、0.821;且三者联合的诊断灵敏度(74.58%)和特异度(86.32%)高于单独诊断;预后良好组与预后不良组患者性别、年龄、BMI、颅脑损伤类型对比无明显差异(P>0.05),预后良好组和预后不良组患者脑挫伤范围、就诊时间、APACHEⅡ评分、平均血流速度、ET-1、IL-6、SIL-2R水平对比差异显著(P<0.05);Logistic回归分析结果表明:APACHEⅡ评分、平均血流速度、ET-1、IL-6、SIL-2R为颅脑损伤后脑血管痉挛预后不良的独立影响因素(P<0.05)。结论:颅脑损伤后重症脑血管痉挛患者血清ET-1、IL-6、SIL-2R水平明显升高,三者联合对于脑血管痉挛的诊断价值较高,且三者为颅脑损伤后脑血管痉挛预后不良的独立影响因素,因此,临床上对于ET-1、IL-6、SIL-2R水平升高的颅脑损伤后脑血管痉挛需及时改良方案,提升患者预后水平。 展开更多
关键词 内皮素-1 白细胞介素-6 可溶性白介素-2受体 颅脑损伤 脑血管痉挛 预后预测
下载PDF
子痫前期患者血清CTRP6、sTNFR-Ⅱ水平及其诊断价值 被引量:2
16
作者 马丽丽 史伟 +1 位作者 唐田田 周明慧 《中国计划生育学杂志》 2023年第3期662-665,共4页
目的:探究子痫前期(PE)患者血清C1q/肿瘤坏死因子相关蛋白6(CTRP6)、可溶性肿瘤坏死因子受体(sTNFR)-Ⅱ水平及其诊断价值。方法:选取2021年6月-2022年6月在本院确诊为PE的患者148例临床资料为PE组,根据病情程度分为轻度PE组(85例)和重... 目的:探究子痫前期(PE)患者血清C1q/肿瘤坏死因子相关蛋白6(CTRP6)、可溶性肿瘤坏死因子受体(sTNFR)-Ⅱ水平及其诊断价值。方法:选取2021年6月-2022年6月在本院确诊为PE的患者148例临床资料为PE组,根据病情程度分为轻度PE组(85例)和重度PE组(63例),常规产前检查健康孕妇75例为对照组。酶联免疫吸附测定法测定各组血清CTRP6、sTNFR-Ⅱ水平;Pearson法分析PE患者血清CTRP6、sTNFR-Ⅱ的相关性;受试者工作特征曲线(ROC)分析CTRP6、sTNFR-Ⅱ对PE发生发展的诊断价值。结果:重度PE组、轻度PE组、对照组尿蛋白定量、ALT、Fib、Cr、收缩压、舒张压水平依次降低,PT值依次增加,血清CTRP6、sTNFR-Ⅱ水平依次降低(均P<0.05)。相关性分析,PE患者血清CTRP6与sTNFR-Ⅱ的表达呈正相关(r=0.354,P<0.001)。ROC曲线分析,CTRP6与sTNFR-Ⅱ联合诊断PE发生的曲线下面积(AUC)(0.975)高于CTRP6、sTNFR-Ⅱ单独诊断,其敏感度、特异性分别为79.7%和92.3%;诊断重度PE的AUC为0.925,敏感度、特异性分别为39.7%和98.8%,高于CTRP6和sTNFR-Ⅱ单独诊断(均P<0.001)。结论:PE患者血清CTRP6、sTNFR-Ⅱ水平异常升高,二者与疾病严重程度有关,且联合诊断可提高PE的诊断效能。 展开更多
关键词 子痫前期 C1q/肿瘤坏死因子相关蛋白6 可溶性肿瘤坏死因子受体-Ⅱ
下载PDF
Diagnostic and prognostic roles of soluble CD22 in patients with Gram-negative bacterial sepsis 被引量:4
17
作者 Yi-Nan Jiang Xun Cai +5 位作者 Hong-Min Zhou Wei-Dong Jin Min Zhang Yong Zhang Xiao-Xiao Du Zhong-Hua Klaus Chen 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2015年第5期523-529,共7页
BACKGROUND: Soluble CD22(sCD22) is a fragment of CD22, a B cell-specific membrane protein that negatively regulates B-cell receptor signaling. To date, sCD22 has only been regarded as a tumor marker of B-cell malig... BACKGROUND: Soluble CD22(sCD22) is a fragment of CD22, a B cell-specific membrane protein that negatively regulates B-cell receptor signaling. To date, sCD22 has only been regarded as a tumor marker of B-cell malignancies. Its expression in infectious diseases has not yet been assessed.METHODS: Serum concentrations of sCD22, procalcitonin(PCT) and interleukin-6(IL-6) were measured by enzymelinked immunosorbent assays in patients with intra-abdominal Gram-negative bacterial infection. Receiver operating characteristic curve analysis was performed to evaluate the diagnostic accuracy of these biomarkers in this type of infection. The correlations between biomarkers and the Acute Physiology and Chronic Health Evaluation(APACHE) II scores were also analyzed.RESULTS: Concentrations of sCD22 were significantly elevated in patients with sepsis and the elevation is correlated with the severity of sepsis. sCD22 was also slightly elevated in patients with non-infected systemic inflammatory response syndrome or local infection. The diagnostic accuracy of sCD22 for sepsis was equivalent to that of PCT or IL-6. In addition, the correlation of sCD22 with APACHE II scores was stronger than that of PCT or IL-6.CONCLUSIONS: Serum sCD22 is a novel inflammatory mediator released during infection. This soluble biomarker plays a potential role in the diagnosis of Gram-negative bacterial sepsis, with a diagnostic accuracy as efficient as that of PCT or IL-6. Furthermore, sCD22 is more valuable to predict the outcomes in patients with sepsis than PCT or IL-6. The present study suggested that sCD22 might be potentially useful in supplementing current criteria for sepsis. 展开更多
关键词 soluble CD22 procalcitonin interleukin-6 sepsis systemic inflammatory response syndrome
下载PDF
Severe acute respiratory syndrome coronavirus 2 infection: Role of interleukin-6 and the inflammatory cascade 被引量:2
18
作者 Mohaddeseh Bahmani Rojin Chegini +6 位作者 Elham Ghanbari Elham Sheykhsaran Parisa Shiri Aghbash HamedEbrahimzadeh Leylabadlo Ehsan Moradian Amir Masoud Kazemzadeh Houjaghan Hossein Bannazadeh Baghi 《World Journal of Virology》 2022年第3期113-128,共16页
Since December 2019,a novel coronavirus that represents a serious threat to human lives has emerged.There is still no definite treatment for severe cases of the disease caused by this virus,named coronavirus disease 2... Since December 2019,a novel coronavirus that represents a serious threat to human lives has emerged.There is still no definite treatment for severe cases of the disease caused by this virus,named coronavirus disease 2019(COVID-19).One of the most considered treatment strategies targets the exaggerated immune regulator,and interleukin(IL)-6 is a crucial pro-inflammatory mediator.Severe acute respiratory syndrome coronavirus 2(SARSCoV-2)cases show an elevated level of IL-6 related to disease severity.IL-6 activity can be inhibited by the following:IL-6 itself,IL-6 signaling pathways such as Janus kinase and signal transducer and activator of transcription(JAK-STAT),gp130,IL-6R,and downstream activated ILs,such as IL-17 and IL-6 cytokine.Currently,according to these studies and their results,IL-6 blockade with anti-IL-6 or its receptor antibodies such as tocilizumab in COVID-19 is beneficial in severe cases and may reduce the mortality rate.JAK-STAT inhibitors block the cytokine storm by inhibiting several crucial pro-inflammatory mediators such as TNF-αand IL-6 and have shown various results in clinical trials.IL-6 induces IL-17 secretion,and IL-17 is involved in the pathogenesis of inflammatory processes.Clinical trials of anti-IL-17 drugs are currently recruiting,and anti-gp130 antibody is preclinical.However,this agent has shown positive effects in inflammatory bowel disease clinical trials and could be tested for SARS-CoV-2.This study aimed to review the role of IL-6 in the cytokine storm and studies regarding IL-6 and blockade of its inflammatory pathways in COVID-19 to determine if any of these agents are beneficial for COVID-19 patients. 展开更多
关键词 Anti-interleukin-6 COVID-19 INFLAMMATION interleukin-6 interleukin-6 receptor SARS-CoV-2
下载PDF
Chemokine receptor 8 expression may be linked to disease severity and elevated interleukin 6 secretion in acute pancreatitis 被引量:1
19
作者 Mwangala Nalisa Ekene Emmanuel Nweke +5 位作者 Martin D Smith Jones Omoshoro-Jones John WS Devar Rebecca Metzger Tanya N Augustine Pascaline N Fru 《World Journal of Gastrointestinal Pathophysiology》 2021年第6期115-133,共19页
BACKGROUND Acute pancreatitis(AP)is an inflammatory disease,which presents with epigastric pain and is clinically diagnosed by amylase and lipase three times the upper limit of normal.The 2012 Atlanta classification s... BACKGROUND Acute pancreatitis(AP)is an inflammatory disease,which presents with epigastric pain and is clinically diagnosed by amylase and lipase three times the upper limit of normal.The 2012 Atlanta classification stratifies the severity of AP as one of three risk categories namely,mild AP(MAP),moderately severe AP(MSAP),and severe AP(SAP).Challenges in stratifying AP upon diagnosis suggest that a better understanding of the underlying complex pathophysiology may be beneficial.AIM To identify the role of the chemokine receptor 8(CCR8),expressed by T-helper type-2 Lymphocytes and peritoneal macrophages,and its possible association to Interleukin(IL)-6 and AP stratification.METHODS This study was a prospective case-control study.A total of 40 patients were recruited from the Chris Hani Baragwanath Academic Hospital and the Charlotte Maxeke Johannesburg Academic Hospital.Bioassays were performed on 29 patients(14 MAP,11 MSAP,and 4 SAP)and 6 healthy controls as part of a preliminary study.A total of 12 mL of blood samples were collected at Day(D)1,3,5,and 7 post epigastric pain.Using multiplex immunoassay panels,real-time polymerase chain reaction(qRT-PCR)arrays,and multicolour flow cytometry analysis,immune response-related proteins,genes,and cells were profiled respectively.GraphPad Prism^(TM) software and fold change(FC)analysis was used to determine differences between the groups.P<0.05 was considered significant.RESULTS The concentration of IL-6 was significantly different at D3 post epigastric pain in both the MAP group and MSAP group with P=0.001 and P=0.013 respectively,in a multiplex assay.When a FC of 2 was applied to identify differentially expressed genes using RT2 Profiler,CCR8 was shown to increase steadily with disease severity from MAP(1.33),MSAP(38.28)to SAP(1172.45)median FC.Further verification studies using RT-PCR showed fold change increases of CCR8 in MSAP and SAP ranging from 1000 to 1000000 times when represented as Log10,compared to healthy control respectively at D3.The findings also showed differing lymphocyte and monocyte cell frequency between the groups.With monocyte population frequency as high as 70%in MSAP at D3.CONCLUSION The higher levels of CCR8 and IL-6 in the severe patients and immune cell differences compared to MAP and controls provide an avenue for exploring AP stratification to improve management. 展开更多
关键词 Acute Pancreatitis Severity Stratification interleukin-6 Chemokine receptor 8 LYMPHOCYTES MONOCYTES
下载PDF
全球急性冠状动脉事件注册评分联合血清可溶性白细胞介素6受体水平对急性心肌梗死患者术后主要不良心血管事件发生风险的预测价值 被引量:4
20
作者 黄舒洁 洪达 林圣美 《中国医药》 2023年第2期178-182,共5页
目的探讨全球急性冠状动脉事件注册(GRACE)评分联合血清可溶性白细胞介素6受体(sIL-6R)水平对急性心肌梗死(AMI)患者术后主要不良心血管事件(MACE)发生风险的预测价值。方法选取2020年6月至2021年6月福建省立医院收治的116例行经皮冠状... 目的探讨全球急性冠状动脉事件注册(GRACE)评分联合血清可溶性白细胞介素6受体(sIL-6R)水平对急性心肌梗死(AMI)患者术后主要不良心血管事件(MACE)发生风险的预测价值。方法选取2020年6月至2021年6月福建省立医院收治的116例行经皮冠状动脉介入治疗的AMI患者,根据术后6个月内是否发生MACE分为MACE组和无MACE组。入院后进行GRACE评分,采用酶联免疫吸附试验法检测患者血清sIL-6R水平,比较2个指标和一般资料的组间差异,分析GRACE评分联合sIL-6R水平对AMI患者术后MACE发生风险的预测价值。结果无MACE组纳入81例患者,MACE组纳入35例患者。MACE组患者心率、心力衰竭病史比例均高于无MACE组,舒张压、收缩压均低于无MACE组(均P<0.05)。MACE组患者GRACE评分和血清sIL-6R水平均高于无MACE组(均P<0.001)。多因素Logistic回归分析结果显示,GRACE评分≥138分(比值比=2.843,95%置信区间:1.498~5.397)、血清sIL-6R水平≥439.56 kU/L(比值比=3.121,95%置信区间:1.373~7.094)是AMI患者术后发生MACE的独立危险因素(均P<0.05)。受试者工作特征曲线分析结果显示,GRACE评分和血清sIL-6R水平联合预测AMI患者术后MACE发生风险的曲线下面积为0.861(95%置信区间:0.823~0.889),敏感度和特异度分别为83.54%和76.22%。结论AMI术后发生MACE患者GRACE评分和血清sIL-6R水平升高,二者联合对AMI术后MACE发生风险具有较好预测价值。 展开更多
关键词 急性心肌梗死 全球急性冠状动脉事件注册评分 可溶性白细胞介素6受体 主要不良心血管事件
下载PDF
上一页 1 2 8 下一页 到第
使用帮助 返回顶部